75293-96-8

Upstream product

• 625-58-1 ethyl nitrate 
• 24108-97-2 3,4-dibromoacetanilide 
• 627-13-4 propyl nitrate 

Downstream Products

• 75293-97-9 2-nitro-4,5-dibromoaniline 
• 66127-00-2 3,5,6,8-tetrabromo-1,10-phenanthroline 
• 66126-99-6 3,5,6-Tribrom-[1,10]phenanthrolin 
• 56290-06-3 5,6-dibromo-1,10-phenanthroline 

Relevant academic research and scientific papers

Heterocyclic topoisomerase poisons

The invention provides a topoisomerase poison of formula I: wherein R1-R8 have any of the meanings defined in the specification, or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions comprising a compound of formula I or a salt thereof, intermediates useful for preparing a compound of formula I, and therapeutic methods comprising administering a compound of formula I or a salt thereof.

Salts of dihalo-3,4-dihydro-3-oxo-2-quinoxaline carboxylic acids and hindered amines

Salts of 6,7-dihalo-3,4-dihydro-3-oxo-2-quinoxaline carboxylic acids and hindered amines, useful in combating influenza A and B.

Treatment of influenza with 2-estersubstituted-3,4-dihydro-3-oxoquinoxalines

3,4-Dihydro-3-oxoquinoxalines carrying a carboxylic acid or ester function in the 2 position, used as antiviral agents, particularly against influenza virus, both A and B strains.

Antiviral combinations

Antiviral combinations containing a 2-ester-substituted-3,4-dihydro-3-oxoquinoxaline and a hindered amine.